Keyphrases
Type 2 Diabetes Mellitus (T2DM)
94%
CB-TE2A
66%
Vitamin D Deficiency
52%
Early-onset Type 2 Diabetes
43%
Treatment Options
43%
Youth Studies
43%
Osteoclast
31%
Hemoglobin A1c (HbA1c)
31%
Insulin Sensitivity
30%
C(RGDyK)
29%
Integrin
27%
Insulin Resistance
26%
Vitamin D
25%
Cu(II)
25%
Endoplasmic Reticulum Stress (ER stress)
24%
Imaging Agents
23%
Copper-64 (64Cu)
23%
Pediatric Patients
21%
Cross-bridged Tetraazamacrocycle
20%
Osteolytic Metastasis
20%
Macrocyclic Chelators
20%
Macrophage Phenotype
20%
Counterregulatory Response
18%
Maternal Complications
18%
Youth-onset
18%
Diabetic Pregnancy
18%
RGD Peptide
18%
Diabetes Self-management
18%
Physiologic
18%
Hypoglycemia
18%
Positron Emission Tomography-computed Tomography (PET-CT)
18%
Uncontrolled Type 2 Diabetes
18%
Small Animal PET
18%
Amide Compound
18%
Cardiac Outcomes
18%
Non-invasive Imaging
18%
Hematopoietic Stem Cells
18%
Vascular Outcomes
18%
Metastatic Tumor Model
18%
Insulin Therapy
18%
Puberty
18%
Pregnancy Outcome
18%
Osteolysis
18%
Response Predictors
18%
Intact Parathyroid Hormone (iPTH)
18%
Young Women
18%
Peptide Conjugates
18%
EC50
18%
Antiatherogenic
18%
Type 2 Diabetic Patients
18%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Vitamin D
55%
Copper 64
50%
Diabetes in Adolescents
46%
Pediatrics
41%
Vitamin D Deficiency
39%
Hypovitaminosis D
39%
Bariatric Surgery
37%
Macrophage
36%
Hemoglobin A1c
31%
Endoplasmic Reticulum Stress
27%
Neoplasm
26%
Integrin
23%
Pediatrics Patient
21%
Diabetes
21%
Chelating Agent
21%
Atherosclerosis
20%
In Vitro
20%
Body Mass Index
19%
Insulin Treatment
18%
Cardiovascular System
18%
Ultrafiltration
18%
Tail
18%
Menstruation
18%
Metastatic Carcinoma
18%
Diabetes Mellitus
18%
Tumor Model
18%
Bone Metastasis
18%
Positron Emission Tomography-Computed Tomography
18%
Matrix Metalloproteinase
18%
Hypoglycemia
18%
Menstruation Disorder
18%
Hematopoietic Cell
18%
Hypertension
18%
Papillary Thyroid Cancer
18%
Setmelanotide
18%
Tetraxetan
15%
Osteoclast
15%
Biodistribution
14%
Sex Hormone
13%
Gelatinase A
13%
Adipose Tissue
12%
Insulin Resistance
12%
Vertebra
12%
Insulin Sensitivity
9%
Arterial Stiffness
9%
Pregnancy
9%
Household
9%
Retinopathy
9%
Proportional Hazards Model
9%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Copper 64
69%
Vitamin D
37%
Hemoglobin A1c
31%
Neoplasm
29%
Bone Metastasis
29%
Integrin
26%
Chelating Agent
24%
Vitamin D Deficiency
20%
Hypovitaminosis D
20%
Biodistribution
18%
Metastasis
18%
Diabetes Mellitus
18%
Matrix Metalloproteinase
18%
Tumor Model
18%
Parathyroid Hormone
18%
Polyethylene Terephthalate
18%
Thyroid Papillary Carcinoma
18%
Setmelanotide
18%
Tetraxetan
15%
Gelatinase A
13%
Insulin Resistance
12%
EC50
10%
Neuropathy
9%
Clinical Trial
9%
Retinopathy
9%
Cell Adhesion Proteins
9%
Bisphosphonic Acid Derivative
9%
Malignant Neoplasm
9%
Tracer
7%
Sodium Thiopental
7%
Bone Disease
7%
Bone Lesion
6%
Bone Atrophy
6%
Cuprous Ion
6%
Zoledronic Acid
6%
Diseases
6%
Hexadecane
5%
Adiponectin
5%
Metformin
5%
Gelatinase B
5%
Gelatinase
5%
Somatostatin Receptor
5%